Works matching IS 17562856 AND DT 2017 AND VI 10 AND IP 9
Results: 3
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 9, p. 315, doi. 10.1177/1756285617721092
- By:
- Publication type:
- Article
Edaravone: a baby in the bathwater?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 9, p. 313, doi. 10.1177/1756285617720351
- By:
- Publication type:
- Article
The role of natalizumab in the treatment of multiple sclerosis: benefits and risks.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 9, p. 327, doi. 10.1177/1756285617716002
- By:
- Publication type:
- Article